What is NDC 0093-4175?

0093-4175 is the product NDC for Cephalexin, Cephalexin 125 mg/5mL powder, for suspension, listed with the FDA by Teva Pharmaceuticals USA, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

Teva Pharmaceuticals USA, Inc., NDC labeler code 0093. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Cephalexin?

183 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Cephalexin NDC 0093-4175 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0093-4175Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00093-4175Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0093-4175-73	0009341757300093417573	100 mL in 1 BOTTLE (0093-4175-73)Marketed from Sep 30, 1990
0093-4175-74	0009341757400093417574	200 mL in 1 BOTTLE (0093-4175-74)Marketed from Sep 30, 1990

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cephalexin
Generic name (nonproprietary): cephalexin
Active ingredients: Cephalexin — 125 mg/5mL
Dosage form: Powder, For suspension
Route: Oral
Labeler: Teva Pharmaceuticals USA, Inc.NDC labeler code 0093
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 062703
Marketing start: Sep 30, 1990
Listing expires: Dec 31, 2027
Other FDA classes: Cephalosporins (Chemical structure)
Identifiers: Product ID 0093-4175_0f364531-c5d4-47f1-9b50-cf7dccafa4e9SPL ID 0f364531-c5d4-47f1-9b50-cf7dccafa4e9
Pharmacologic class: Cephalosporin Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400093417573 followed by a unit qualifier and the quantity

Package 00093-4175-73. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 0093-4175

What is NDC 0093-4175?: 0093-4175 is the product NDC for Cephalexin, Cephalexin 125 mg/5mL powder, for suspension, listed with the FDA by Teva Pharmaceuticals USA, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Cephalexin.
What is the active ingredient?: Cephalexin.
Who is the labeler?: Teva Pharmaceuticals USA, Inc., NDC labeler code 0093. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Cephalexin?: 183 other product NDCs are listed under this name. See all Cephalexin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Cephalexin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Cephalexin	Cephalexin 500 mg/1	CapsuleOral	Preferred Pharmaceuticals Inc.	68788-4143	68788-4143-0168788-4143-0268788-4143-03+6 more
Cephalexin	Cephalexin 250 mg/1	CapsuleOral	Preferred Pharmaceuticals Inc.	68788-4167	68788-4167-0268788-4167-0368788-4167-04+3 more
Cephalexin	Cephalexin 125 mg/5mL	Powder, For suspensionOral	Aurobindo Pharma Limited	59651-322	59651-0322-0159651-0322-02
Cephalexin	Cephalexin 250 mg/5mL	Powder, For suspensionOral	Aurobindo Pharma Limited	59651-323	59651-0323-0159651-0323-02
Cephalexin	Cephalexin 500 mg/1	CapsuleOral	Coupler LLC	67046-1245	67046-1245-03
Cephalexin	Cephalexin 250 mg/1	CapsuleOral	AVKARE	42291-006	42291-0006-50
Cephalexin	Cephalexin 500 mg/1	CapsuleOral	AVKARE	42291-007	42291-0007-50
Cephalexin	Cephalexin 500 mg/1	CapsuleOral	Northwind Health Company, LLC	82868-095	82868-0095-1082868-0095-2082868-0095-21+3 more
Cephalexin	Cephalexin 250 mg/5mL	For suspensionOral	REMEDYREPACK INC.	70518-4511	70518-4511-00
Cephalexin	Cephalexin 250 mg/1	CapsuleOral	Coupler, LLC	67046-1533	67046-1533-03

All 184 Cephalexin NDCs

Other NDCs under ANDA 062703

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 062703
Product	Strength	Form · route	Labeler	Product NDC
Cephalexin	Cephalexin 250 mg/5mL	Powder, For suspensionOral	Teva Pharmaceuticals USA, Inc.	0093-4177
Cephalexin	Cephalexin 250 mg/5mL	Powder, For suspensionOral	Proficient Rx LP	63187-205
Cephalexin	Cephalexin 250 mg/5mL	Powder, For suspensionOral	NuCare Pharmaceuticals,Inc.	66267-982